Clinical significances and expressions of inflammatory marker interleukin-13 in peripheral blood of patients with polycystic ovary syndrome
返回论文页
|更新时间:2023-12-18
|
Clinical significances and expressions of inflammatory marker interleukin-13 in peripheral blood of patients with polycystic ovary syndrome
Journal of Chongqing Medical UniversityVol. 36, Issue 5, Pages: 546-550(2013)
作者机构:
重庆市万州区中西医结合医院妇产科,万州,404000
作者简介:
基金信息:
DOI:
CLC:
Published:2013,
扫 描 看 全 文
NIE Gelian. Clinical significances and expressions of inflammatory marker interleukin-13 in peripheral blood of patients with polycystic ovary syndrome. [J]. Journal of Chongqing Medical University 36(5):546-550(2013)
DOI:
NIE Gelian. Clinical significances and expressions of inflammatory marker interleukin-13 in peripheral blood of patients with polycystic ovary syndrome. [J]. Journal of Chongqing Medical University 36(5):546-550(2013)DOI:
Clinical significances and expressions of inflammatory marker interleukin-13 in peripheral blood of patients with polycystic ovary syndrome
Objective:To observe the expressions of interleukin-13(IL-13) in peripheral blood of patients with polycystic ovary syn-drome(PCOS) and to analyze their relationship with the body mass index(BMI),reproductive relevant hormone,fasting blood glucose (FBG) and blood fat. Methods:Clinical control trial was carried out. All patients were assigned to three groups:PCOS with obesity (40 cases),PCOS with non-obesity(35 cases) and controls(39 cases). Body weight,body height,waist circumference and hip cir-cumference were measured and BMI and waist/hip ratio(WHR) were calculated. Enzyme-linked immuno sorbent assay(ELISA) kit for IL-13 was used to test the expression in peripheral blood. Chemiluminescence method was applied to detect FBG,fasting insulin(Ins),cholesterol(TC),triglycerides(TG),high-density lipoprotein(HDL) and low-density lipoprotein(LDL) level for the patients in three groups. Reproductive hormones including follicle-stimulating hormone(FSH),corpus luteum erythropoietin(LH),estradiol(E2),progesterone(P),prolactin(PRL) and testosterone(T) were assayed by radiation immunoassays(RI). Results:Expression of IL-13 in peripheral blood was higher in PCOS with obesity than in PCOS with non-obesity(P=0.000) and that was higher in PCOS with obesi-ty and PCOS with non-obesity than in controls(P=0.000;P=0.019). Serum levels of Ins,LDL,HDL,TG,TC,IR,E2,FSH and P were not statistically different. Serum levels of WHR,BMI,FBG,LH and T were higher in PCOS with obesity and PCOS non-obesity than in controls. Simple correlated regression analysis showed that IL-13 was correlated with BMI(R=0.527,P=0.000),FBG(R=0.449,P=0.000),WHR (R=0.272,P=0.021),LH(R=0.247,P=0.037) and T(R=0.452,P=0.000) and multiple linear regression formula was IL-13=90.814+1.255BMI+0.755WHR+1.696FBG+0.146LH+0.738T. Conclusions:Expression of inflammatory marker IL-13 is in-creased in the peripheral blood of PCOS patients and has positive correlation with BMI,WHR,FBG,LH and T indexes.
Clinical efficacy of Liraglutide combined with metformin in overweight or obese patients with PCOS
Comparison of remission of metformin,pioglitazone and their combination on early abnormal glucose metabolism in patients with polycystic ovary syndrome
A mouse model of polycystic ovary syndrome with abnormal glucose and lipid metabolism induced by dihydrotestosterone combined with high-fat diet
Development and validation of an insulin sensitivity score in female with polycystic ovary syndrome
Chronic inflammation aggravates hepatic glucose metabolism disorder in obese mice
Related Author
Liao Mingyu
Shen Rufei
Liao Qian
Zhou Ling
Ran Chenxi
Li Xiaorong
Min Long
Liu Qicong
Related Institution
Department of Endocrinology,The Second Affiliated Hospital of Army Medical University
Department of Endocrinology,The First Affiliated Hospital of Army Medical University
Endocrinology and Metabolism Department,The Second Affiliated Hospital of Chongqing Medical University
Department of Endocrinology,Chongqing Traditional Chinese Medicine Hospital
Department of Endocrinology,The Second Affiliated Hospital of Chongqing Medical University